3
Views
8
CrossRef citations to date
0
Altmetric
Articles

Effect of Treatment with a Bile-sequestering Agent (Secholex®) on Intestinal Absorption, Duodenal Bile Acids, and Plasma Lipids

, , , , &
Pages 791-800 | Received 06 Jun 1975, Accepted 18 Jul 1975, Published online: 16 Oct 2020
 

Abstract

Ritland, S., Fausa, O., Gjone, E., Blomhoff, J. P., Skrede, S. & Lanner, A. Effect of treatment with a bile-sequestering agent (Secholex®) on intestinal absorption, duodenal bile acids, and plasma lipids. Scand. J. Gastroent. 1975, 10, 791-800.

Four female and five male patients (mean age 26 years) with hyperlipo-proteinaemia type II A were treated with an anion exchange gel (Secholex®) 9 g/day for 3 months and 15 g/day for 9 months. After these 12 months clofibrate 1.5 g/day was added to the therapy in 6 patients, whereas 2 patients continued with the resin alone for another 6 months, and one was withdrawn from the trial because of pregnancy. During the first year plasma cholesterol decreased averagely 18% from a mean pretreatment value of 461 mg/100 ml. Dosis of 9 g/day seemed to be as efficient as 15 g/day. When clofibrate was added, a further decrease of plasma cholesterol by 6% was observed, and the levels of triglycerides were reduced. Significantly increased concentrations of bile acids and a rise in the glycine/taurine ratio in duodenal aspirate were caused by the resin. On combined treat-ment the concentration of bile acids decreased to the pretreatment values, whereas the glycine/taurine ratio remained unchanged. During the trial slight transient changes in serum folic acid, fasting insulin, calcium, alkaline phosphatases, and vitamin Bi2-absorption occurred. No changes in serum vitamin A, vitamin-K-dependent clotting factors, serum gastrin, gastric acid output, the absorption of glucose and iron, and the faecal excretion of fat were observed. Serum insulin 30 and 60 minutes after an oral glucose loading decreased in the patients on combined treatment, whereas the insulin response remained normal in patients taking Secholex alone. Liver function tests and creatinine were unchanged during the trial. Apart from transient abdominal discomfort in two patients, no side-effects were discovered. The patients found the gel palatable.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.